Ultra-High-Risk Gestational Choriocarcinoma of the Ovary Associated with Ectopic Pregnancy.
Eva Pavla MalovrhNuša LukinovičTatjana BujasMonika SobocanJure KnezPublished in: Current oncology (Toronto, Ont.) (2023)
Gestational choriocarcinoma of the ovary is an exceptionally rare and highly aggressive tumor. Preoperative diagnosis of extrauterine choriocarcinoma is difficult due to nonspecific clinical presentation and its resemblance to ectopic pregnancy. Without molecular genetic analysis, it is not possible to reliably differentiate gestational from non-gestational choriocarcinoma. Here, we present a case of a 44-year-old woman who presented to our emergency department with complaints of pelvic pain, vaginal bleeding, and amenorrhea. Because of a recent history of conservatively managed ectopic pregnancy, the patient underwent emergency laparoscopy. Right-sided salpingo-oophorectomy was performed due to intraoperatively suspected ovarian ectopic pregnancy. Histopathology results revealed the diagnosis of ovarian choriocarcinoma of possible gestational origin. It was classified as FIGO stage IV and WHO ultra-high-risk, and she underwent multi-agent chemotherapy without major complications. She has remained in complete remission after a 12-month follow-up. Considering the rarity of this diagnosis, we conducted a literature review including all published cases of suspected gestational choriocarcinomas of the ovary. We conclude that due to the rarity of this entity, preoperative differentiating between ovarian ectopic pregnancy and ovarian choriocarcinoma is extremely challenging, and without molecular genetic analysis, it is not possible to identify the genetic origin of the tumor.
Keyphrases
- pregnancy outcomes
- weight gain
- pregnant women
- emergency department
- preterm birth
- birth weight
- body mass index
- high resolution
- patients undergoing
- healthcare
- public health
- chronic pain
- radiation therapy
- squamous cell carcinoma
- systemic lupus erythematosus
- magnetic resonance imaging
- atrial fibrillation
- mass spectrometry
- computed tomography
- gene expression
- spinal cord
- rectal cancer
- magnetic resonance
- locally advanced
- meta analyses
- adverse drug